Contributed by: Dennis Fortier, President, Medical Care Corporation
________________________________________________
With today's news about the failure of the Dimebon trial, it may be a good time for a refresher on the FDA drug approval process. Last April, this succinct summary was posted by Dr. Michael Rafii.
This blog is non commercial and seeks only to educate. If you find it useful and informative, then please consider sharing it with your online networks via the share button below.
Subscribe to:
Post Comments
(
Atom
)
Posts
Thank you for sharing this information, The information was very helpful and saved a lot of my time, Thank you for providing this information
ReplyDelete